CareLit · DOI-Nachweis · Klinische Neurophysiologie
„Compliant 2006“ – The value of valproate granules in the therapy of patients with epilepsy. An observational study in 272 patients
DOI 10.1055/s-2008-1072930
Bibliografische Angaben
Nachweis in CareLit
Autor:innenKJ Werhahn, S Kuehne, G Lippert, S Klimpe
ZeitschriftKlinische Neurophysiologie
Ausgabe04/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Sodium valproate is available as a modified-release formulation consisting of tasteless granules (VPA-G, Ergenyl® Chronosphere®). It has been postulated that this formulation potentially reduces adverse events, improves the convenience of intake (once-daily dosage regimen) having a positive effect on compliance, which may lead to an increased clinical effectiveness. To challenge this hypothesis a prospec…
Zitieren
Zitierempfehlung
KJ Werhahn, S Kuehne, G Lippert, S Klimpe (2008) „Compliant 2006“ – The value of valproate granules in the therapy of patients with epilepsy. An observational study in 272 patients. Klinische Neurophysiologie (04). https://doi.org/10.1055/s-2008-1072930
Mit CareLit weiterarbeiten